Long-term, antidiabetogenic effects of GLP-1 gene therapy using a double-stranded, adeno-associated viral vector (Q45862933)

17 December 2017

title

Long-term, antidiabetogenic effects of GLP-1 gene therapy using a double-stranded, adeno-associated viral vector (English)

1 reference

17 December 2017

0 references

S H Choi

1

1 reference

17 December 2017

H C Lee

series ordinal

2

1 reference

17 December 2017

publication date

19 August 2010

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

18

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

155-163

1 reference

17 December 2017

Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37).

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Glucose and tolbutamide induce apoptosis in pancreatic beta-cells. A process dependent on intracellular Ca2+ concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

The Physiology of Glucagon-like Peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Adeno-associated viral delivery of a metabolically regulated insulin transgene to hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Gene delivery to intestinal epithelial cells in vitro and in vivo with recombinant adeno-associated virus types 1, 2 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Widespread and stable pancreatic gene transfer by adeno-associated virus vectors via different routes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

The glucagon-like peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits beta-cell apoptosis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Ectopic expression of glucagon-like peptide 1 for gene therapy of type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Prospects for the use of adeno-associated virus as a vector for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

The cryptic life style of adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Adeno-associated virus vectors for gene therapy: more pros than cons?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

The state of the art of adeno-associated virus-based vectors in gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Novel dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1(7-36)amide have preserved biological activities in vitro conferring improved glucose-lowering action in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Mechanisms of action of glucagon-like peptide 1 in the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Roles of CHOP/GADD153 in endoplasmic reticulum stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

7 January 2021

Glucagon-like peptides

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

7 January 2021

Exendin-4, a new peptide from Heloderma suspectum venom, potentiates cholecystokinin-induced amylase release from rat pancreatic acini

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

7 January 2021

Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

7 January 2021

Protection of pancreatic beta-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

7 January 2021

Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

7 January 2021

Quantitative characterization of furin specificity. Energetics of substrate discrimination using an internally consistent set of hexapeptidyl methylcoumarinamides

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

7 January 2021

The genetics of diabetes susceptibility in mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.119

7 January 2021

Identifiers

DOI

10.1038/GT.2010.119

1 reference

17 December 2017

Dimensions Publication ID

1014343875

0 references

1 reference

17 December 2017